68 related articles for article (PubMed ID: 33047677)
1. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
[TBL] [Abstract][Full Text] [Related]
2. Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.
Caspers IA; Biesma HD; Wiklund K; Pontén F; Lind P; Nordsmark M; Sikorska K; Meershoek-KleinKranenbarg E; Hartgrink HH; van de Velde CJH; van Sandick JW; Verheij M; Cats A; van Grieken NCT
Gastric Cancer; 2024 Jan; 27(1):102-109. PubMed ID: 37947918
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.
Min L; Zhao Y; Zhu S; Qiu X; Cheng R; Xing J; Shao L; Guo S; Zhang S
Transl Oncol; 2017 Feb; 10(1):99-107. PubMed ID: 28013168
[TBL] [Abstract][Full Text] [Related]
4. The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
Caspers IA; Slagter AE; Lind P; Sikorska K; Wiklund K; Pontén F; Nordsmark M; van de Velde CJH; Kranenbarg EM; van Sandick JW; Jansen EPM; van Laarhoven HWM; Verheij M; van Grieken NCT; Cats A
J Surg Oncol; 2024 Mar; 129(4):734-744. PubMed ID: 38073160
[TBL] [Abstract][Full Text] [Related]
5. Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.
Ulase D; Behrens HM; Röcken C
Virchows Arch; 2024 May; ():. PubMed ID: 38748262
[TBL] [Abstract][Full Text] [Related]
6. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
[TBL] [Abstract][Full Text] [Related]
7. Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score).
Puhr HC; Puhr R; Kuchling DA; Jahic L; Takats J; Reiter TJ; Paireder M; Jomrich G; Schoppmann SF; Berghoff AS; Preusser M; Ilhan-Mutlu A
ESMO Open; 2022 Aug; 7(4):100519. PubMed ID: 35759854
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of the log odds of positive lymph nodes in Western patients with resected gastric cancer: A comparison with the 8th edition of the TNM staging system.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Am J Clin Pathol; 2024 Feb; 161(2):186-196. PubMed ID: 37901915
[TBL] [Abstract][Full Text] [Related]
9. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.
Cisło M; Filip AA; Arnold Offerhaus GJ; Ciseł B; Rawicz-Pruszyński K; Skierucha M; Polkowski WP
Oncotarget; 2018 Apr; 9(27):19427-19442. PubMed ID: 29721214
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a clinicopathological prognostic score for resected gastric cancer patients.
DIaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Ortega Medina L; García Gómez de Las Heras S; Chávez Á; Fernández Aceñero M
Saudi J Gastroenterol; 2021; 27(1):44-53. PubMed ID: 33047677
[TBL] [Abstract][Full Text] [Related]
11. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
[TBL] [Abstract][Full Text] [Related]
12. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.
Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Molina Roldán E; Cerón Nieto MÁ; García Gómez de Las Heras S; Fernández Aceñero MJ
World J Gastrointest Oncol; 2022 Jun; 14(6):1162-1174. PubMed ID: 35949214
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
